• Home
  • Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al.

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al.

Author List
Chheda ZS, Mueller S, Hegde B, Yamamichi A, Butterfield LH, Okada H
Publication
Journal for immunotherapy of cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/383941471
Publication Year
2023
PubMed ID
36944450
Publication Title
Chheda ZS, Mueller S, Hegde B, Yamamichi A, Butterfield LH, Okada H. Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al. J Immunother Cancer. 2023 03; 11(3).